Chief Operating Officer Acuitas Therapeutics As Chief Operating Officer for Acuitas Therapeutics, Abi Coman-Walker develops and oversees the organization’s operational, finance and corporate/business strategy. A qualified accountant (ACMA), Ms. Coman-Walker brings extensive leadership experience to her role at Acuitas, having spent more than 16 years in senior positions for HSBC in seven countries. Ms. Coman-Walker […]
Head Johnson & Johnson Innovation – JLABS Canada Dozie Amuzie is the head of Johnson & Johnson Innovation – JLABS Canada and is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and profit and loss management. He catalyzes and supports the translation of science and technology into valuable solutions […]
President, Genomic Medicine Cytiva Emmanuel Abate works to bring out the best in his team so they can better serve the scientific community working on the next medical breakthrough. The Genomic Medicine business includes solutions to help advance the discovery and manufacturing of viral vector, cell therapies, and nucleic acid-based therapies. Emmanuel also leads the […]
Vice-President, Research and Innovation, and Strategic Initiatives, University of Toronto Canada Research Chair in Microbial Genomics & Infectious Disease Co-Director of the CIFAR Fungal Kingdom: Threats & Opportunities program Former Chair of the Department of Molecular Genetics at the University of Toronto Professor Leah Cowen is the Canada Research Chair in Microbial Genomics & Infectious […]
Vice President Cell and Gene Therapy Cytiva Catarina Flyborg is driven by the promise of cell and gene therapies to transform global healthcare, change the way diseases are treated and significantly improve patient outcomes. An accomplished engineer and scientist, Catarina has held various management positions in sales, marketing, communications and product development, giving her a […]
Vice-President, Research and Innovation, and Strategic Initiatives University of Toronto University Professor Edward (Ted) Sargent received a BScEng (Engineering Physics) from Queen’s University and a PhD in Electrical and Computer Engineering (Photonics) from the University of Toronto. He joined the Edward S. Rogers Sr. Department of Electrical and Computer Engineering at the University of Toronto in […]
Chief Scientific Officer, CCRM University of British Columbia Peter Zandstra graduated with a Bachelor of Engineering degree from McGill University in the Department of Chemical Engineering, obtained his Ph.D. degree from the University of British Columbia (UBC) in the Department of Chemical Engineering and Biotechnology and continued his research training as a Post Doctoral Fellow […]
President & Chief Executive Officer CCRM Dr. Michael May completed his PhD in Chemical Engineering at the University of Toronto in 1998 as an NSERC Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. He is President and Chief Executive Officer of CCRM. Prior to CCRM, Michael was the President and co-founder of […]
Managing Director and Senior Biotechnology Analyst JMP Securities Dr. Reni Benjamin is a Managing Director and Senior Biotechnology Analyst at JMP Securities. His coverage consists of small/mid-cap biotechnology companies in the oncology sector. Dr. Benjamin has previously been ranked for recommendation performance and earnings accuracy by StarMine, cited in the Wall Street Journal, Business Week, Financial Times, […]
Founder & CEO Akron Biotechnology Claudia Zylberberg, Ph.D., is a leader in regenerative medicine. She is the founder and CEO of Akron Biotechnology, a leading developer and manufacturer of cGMP-grade ancillary materials and a purveyor of specialized services to cell and gene therapy developers, contract development and manufacturing organizations, and tissue engineering companies, among others. Under Dr. […]
We wish to acknowledge this land on which CCRM operates. For thousands of years, it has been the traditional land of the Huron-Wendat, the Seneca, and the Mississaugas of the Credit. Today, this meeting place is still the home to many Indigenous people from across Turtle Island and we are grateful to have the opportunity to work on this land.
